Friday, September 16, 2016

Astrazeneca says Forxiga combination beats use of drug alone

FRANKFURT, Sept 16 (Reuters) - AstraZeneca said

combining its Forxiga type-2 diabetes drug with older medicine

Bydureon was more effective at controlling blood sugar levels

than treatment with either drug on its own.

Read more

No comments:

Post a Comment